New-Onset Diabetes Mellitus among Parkinsonian Patients Treated with Long-term Quetiapine

Hubert H. Fernandez; Katie M. McCown; Janet Romrell; Martha E. Trieschmann; Joseph H. Friedman; Charles E. Jacobson IV; Michael S. Okun

doi:10.33393/dti.2008.1326

New-Onset Diabetes Mellitus among Parkinsonian Patients Treated with Long-term Quetiapine

Authors

Hubert H. Fernandez Dept. of Neurology, University of Florida, Gainesville, FL.
Katie M. McCown Dept. of Neurology, University of Florida, Gainesville, FL.
Janet Romrell Dept. of Neurology, University of Florida, Gainesville, FL.
Martha E. Trieschmann Dept. of Clinical Neurosciences, Brown University, Providence, RI.
Joseph H. Friedman Dept. of Clinical Neurosciences, Brown University, Providence, RI.
Charles E. Jacobson IV Dept. of Neurology, University of Florida, Gainesville, FL.
Michael S. Okun Dept. of Neurology, University of Florida, Gainesville, FL.

DOI:

https://doi.org/10.33393/dti.2008.1326

Keywords:

quetiapine, diabetes, atypical antipsychotic, parkinson’s disease

Abstract

New-Onset Diabetes Mellitus among Parkinsonian Patients Treated with Long-term Quetiapine

Downloads

Download data is not yet available.

Downloads

Published

2008-03-18

How to Cite

Fernandez, H. H., McCown, K. M., Romrell, J., Trieschmann, M. E., Friedman, J. H., Jacobson IV, C. E., & Okun, M. S. (2008). New-Onset Diabetes Mellitus among Parkinsonian Patients Treated with Long-term Quetiapine. Drug Target Insights, 3(1). https://doi.org/10.33393/dti.2008.1326